Search results

Selected filters:

Market Developments
Europe

Article type

Topic

Sector

Jurisdictions

145 results found for your search

Sort options
30 August 2019

IP market news highlights

Some of the major news stories carried on the IAM platform in June and July

30 August 2019

The Boston Manifesto

While significant progress has been made in increasing and amplifying women in IP-related careers, there is still work to be done. Just before IPBC Global 2019, a group of leaders got together to discuss how best to do this. The result was the Boston Manifesto

29 August 2019

Five things to know about Globalfoundries’ big litigation play

TSMC is the target and nineteen other tech firms are in the crossfire. Here are the takeaways from a big chip sector dispute that’s taking on a trade war tinge

26 August 2019

Three key IP takeaways from Bayer's $7.6 billion sale of its animal health unit

The German company's divestiture to Elanco is the latest example of a pharma giant fleeing non-core business areas - and it is unlikely to be the last

21 August 2019

US removes 5G work exemption from Huawei ban

The Commerce Department extended Huawei’s temporary licence yesterday, but it dropped a provision that allowed technology sharing as part of 5G standards development

12 August 2019

Japan’s Sharp latest to join expanding European auto patent battle

The Foxconn affiliate has joined Nokia in filing German infringement suits against automaker Daimler, recent US court documents show

10 August 2019

A No Deal Brexit now looks unavoidable, so plan accordingly

Boris Johnson becoming Prime Minister has totally changed the trajectory of the UK's departure from the EU and IP owners' strategies should reflect that

18 July 2019

Biometric patent conflict escalates in China

Shenzhen-based Goodix supplies more fingerprint sensors to more phones than any other company. But it is now litigating with two of its biggest rivals in Chinese courts

16 July 2019

Gilead’s unique $5.1 billion licensing deal shows the range of IP monetisation options open to biotech sector

New boss explains that the Big Pharma company will seek out “diverse and creative” asset partnerships – rather than large acquisitions – to boost its pipeline

10 July 2019

All the big life sciences IP developments in June

Our round-up of the major patent issues affecting pharma and biotech that emerged on the legal, market and policy fronts last month

05 July 2019

Get ready for the first CRISPR patent pool

In an exclusive interview, MPEG LA’s Kristin Neuman says that a pool is on its way despite the UCal v Broad stand-off and talks about the future of licensing in biotech’s ‘golden age’

02 July 2019

Japanese aircon giant latest to pledge patent non-aggression

Ten years ago, the company bet big on sharing technology with Chinese upstarts. Now Daikin is opening up a portfolio of refrigerant patents

02 July 2019

AbbVie’s Allergan play designed to mitigate Humira patent cliff

The $63 billion purchase is designed to mitigate the effects of losing the exclusive rights to the world’s best selling drug

27 June 2019

Huawei has reaped $1.4 billion in licence fees since 2015, white paper says

The Chinese company also revealed its royalty outflow – $6 billion since it took its first licence in 2001, 80% of which has gone to US companies

27 June 2019

Everything you wanted to know about AI patents, but were afraid to ask - part 2

After a WIPO report in April, new analysis from the UK IP Office sheds further light on this rapidly growing area and confirms that, despite a Chinese filing surge, the US continues to dominate